arrow
H

Hwan-Jung Yun

Chungnam National University Hospital
H指数:29
被引数:3,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)

在伞形试验(KCSG HN 15-16 TRIUMPH试验)中识别头颈鳞状细胞癌的预测性生物标志物

2025-09-170
PREAI
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
2023-08-222
OAAI
Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia
2021-05-0147
OAAI
Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation
2020-09-2814
OAAI
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗CD30-positive外周T细胞淋巴瘤 (ECHELON-2): 一项全球性、双盲、随机、3期临床试验

LANCET
IF88.5
2019-01-01535
OAAI
Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)

广泛疾病小细胞肺癌患者一线依托泊苷和铂类化疗后帕唑帕尼的维持: 一项多中心,随机,安慰剂对照的II期研究 (KCSG-LU12-07)

2018-01-3036
OAAI
Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)
2016-02-0140
PREAI
Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck
2016-01-2129
OAAI